Board MeetingJun 10, 2026, 07:01 AM
Gain Therapeutics CEO to Present at H.C. Wainwright Summit
AI Summary
Gain Therapeutics, Inc. announced that its President and CEO, Gene Mack, will participate in a virtual fireside chat and one-on-one meetings at the H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit. The fireside chat is scheduled for Monday, June 15, 2026, with a replay available from 7:00 a.m. EDT. This event provides an opportunity for investors to engage with Gain's management and learn more about the company's clinical-stage pipeline, including its lead candidate GT-02287 for Parkinson's disease.
Key Highlights
- CEO Gene Mack to participate in H.C. Wainwright Neuro Perspectives Summit.
- Virtual fireside chat scheduled for Monday, June 15, 2026.
- Replay of fireside chat available starting 7:00 a.m. EDT.
- One-on-one meetings with management available for registered attendees.
- Company is a clinical-stage biotech developing allosteric small molecule therapies.
- Lead candidate GT-02287 is in Phase 1b clinical trial for Parkinson's disease.
Price Impact
More from GANX